Key Takeaways
- • IM8, the Prenetics-owned supplement brand co-founded by David Beckham, secured up to $1B in non-dilutive growth financing from General Catalyst's Customer Value Fund, allowing the company to accelerate customer acquisition without equity dilution.
- • The company achieved $200M in revenue within 18 months and generated $17M in June 2026 revenue, with expectations to reach $300M annualized run rate (ARR) by year-end and project $400M+ for 2027.
- • IM8's business model centers on subscription-first products: a 90-ingredient daily essentials drink mix and a longevity formula featuring NAD+, currently delivering 200,000 servings daily, with planned launches in hydration and gummy categories.
- • Backed by athlete-investors including Giannis Antetokounmpo and Aryna Sabalenka, IM8 is positioned to compete directly with established category leaders such as AG1 and Grüns through accelerated subscription-driven growth.
- • General Catalyst's Customer Value Fund structure demonstrates a shift in growth capital deployment toward predictable, subscription-based revenue models in consumer health, reshaping traditional venture financing dynamics.
Summary
IM8, the health supplement brand co-founded by David Beckham and owned by Prenetics, has closed non-dilutive growth financing of up to $1 billion from General Catalyst's Customer Value Fund. This capital infusion represents a significant validation of the company's subscription-first business model and marks a strategic pivot in how growth-stage consumer health companies are financed.
The company has demonstrated substantial commercial momentum since its launch. IM8 reached $200M in revenue within 18 months of operations and generated $17M in June 2026 revenue alone. Management projects the company will finish 2026 at a $300M annualized run rate and exceed $400M in revenue for 2027. The business operates at significant scale, delivering 200,000 servings daily across its core product lineup. IM8's subscription model comprises two primary offerings: a 90-ingredient daily essentials drink mix and a longevity formula featuring NAD+. The company has product expansion planned, with launches anticipated in hydration and gummy categories.
IM8's investor syndicate reflects broad appeal across professional sports and elite athlete networks. The company counts NBA player Giannis Antetokounmpo and tennis player Aryna Sabalenka among its investor base, alongside Beckham's involvement as co-founder. This athlete-backed positioning provides both distribution leverage and credibility within fitness and wellness consumer segments.
General Catalyst's Customer Value Fund structure represents an emerging alternative to traditional equity financing. The fund subsidizes customer acquisition costs through non-dilutive capital tied to predictable subscription revenue streams, allowing IM8 to maintain ownership stakes while accelerating growth. This approach positions IM8 against established competitors including AG1 and Grüns in the category. The transaction underscores a broader market shift where subscription revenue predictability is unlocking new forms of institutional growth capital for consumer health companies, fundamentally altering scaling dynamics in the supplement and wellness sector.
The company has demonstrated substantial commercial momentum since its launch. IM8 reached $200M in revenue within 18 months of operations and generated $17M in June 2026 revenue alone. Management projects the company will finish 2026 at a $300M annualized run rate and exceed $400M in revenue for 2027. The business operates at significant scale, delivering 200,000 servings daily across its core product lineup. IM8's subscription model comprises two primary offerings: a 90-ingredient daily essentials drink mix and a longevity formula featuring NAD+. The company has product expansion planned, with launches anticipated in hydration and gummy categories.
IM8's investor syndicate reflects broad appeal across professional sports and elite athlete networks. The company counts NBA player Giannis Antetokounmpo and tennis player Aryna Sabalenka among its investor base, alongside Beckham's involvement as co-founder. This athlete-backed positioning provides both distribution leverage and credibility within fitness and wellness consumer segments.
General Catalyst's Customer Value Fund structure represents an emerging alternative to traditional equity financing. The fund subsidizes customer acquisition costs through non-dilutive capital tied to predictable subscription revenue streams, allowing IM8 to maintain ownership stakes while accelerating growth. This approach positions IM8 against established competitors including AG1 and Grüns in the category. The transaction underscores a broader market shift where subscription revenue predictability is unlocking new forms of institutional growth capital for consumer health companies, fundamentally altering scaling dynamics in the supplement and wellness sector.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.